Overview

Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and/or verapamil to learn if their arrhythmias are inducible similarly to sustained ventricular tachycardia.
Phase:
Phase 4
Details
Lead Sponsor:
Weill Medical College of Cornell University
Treatments:
Adenosine
Verapamil